Harry Sloan is Director of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 260,597 shares of DNA, which is worth approximately $2.47 Million. The most recent transaction as insider was on Dec 11, 2024, when has been sold 235,780 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 261K
68.37% 3M change
38.09% 12M change
Total Value Held $2.47 Million

HARRY SLOAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 11 2024
BUY
Other acquisition or disposition
-
235,780 Added 47.5%
260,597 Class A Common Stock
Nov 22 2024
BUY
Other acquisition or disposition
-
4,222 Added 0.51%
828,025 Class A Common Stock
Jun 12 2024
BUY
Exercise of conversion of derivative security
-
105,263 Added 11.33%
823,803 Class A Common Stock
May 14 2024
BUY
Open market or private purchase
$270,833 $0.91 p/Share
297,619 Added 29.29%
718,540 Class A Common Stock
May 18 2023
BUY
Open market or private purchase
$448,000 $1.28 p/Share
350,000 Added 45.4%
420,921 Class A Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
-
70,921 Added 50.0%
70,921 Class A Common Stock

Also insider at

SKLZ
Skillz Inc. Communication Services
LGF-B
LIONS GATE ENTERTAINMENT CORP Communication Services
DKNG
DraftKings Inc. Consumer Cyclical
HS

Harry Sloan

Director
Santa Monica, CA

Track Institutional and Insider Activities on DNA

Follow Ginkgo Bioworks Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA